BioCryst’s drug development technology, pipeline and history


Guest: Dr. Bill Sheridan, Chief Medical Officer, BioCryst Pharmaceuticals, Durham

Topics: BioCryst’s drug development technology, pipeline and history; emergency use of IV peramivir, BioCryst’s anti-influenza drug, in 2009 H1N1 flu epidemic

sheridanphoto.jpg
Dr. Bill Sheridan, Sr. VP and Chief Medical Officer, BioCryst Pharmaceuticals, Inc., Durham

BioCryst Pharmaceuticals, Inc.

New developments in detection, diagnosis, and treatment of autism


Guest: Dr. Geraldine Dawson, research professor of psychiatry, UNC-Chapel Hill; Chief Science Officer, Autism Speaks

dawsonphoto2.jpg
Dr. Geraldine Dawson, Chief Science Officer, Autism Speaks; research professor of psychiatry, UNC-CH

Autism Speaks

The Autism Genome Project

This Emotional Life: Growing Up with Autism (filmed webinar)